Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

55 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
High CDKN2A/p16 and Low FGFR3 Expression Predict Progressive Potential of Stage pT1 Urothelial Bladder Carcinoma.
Breyer J, Wirtz RM, Erben P, Worst TS, Stoehr R, Eckstein M, Bertz S, Sikic D, Denzinger S, Burger M, Hartmann A, Otto W; Bladder Cancer Research Initiative for Drug Targets Germany (BRIDGE) Consortium eV, Mannheim, Germany. Breyer J, et al. Among authors: worst ts. Clin Genitourin Cancer. 2018 Aug;16(4):248-256.e2. doi: 10.1016/j.clgc.2018.01.009. Epub 2018 Feb 2. Clin Genitourin Cancer. 2018. PMID: 29525349
Peritoneal Flap for Lymphocele Prophylaxis Following Robotic-assisted Radical Prostatectomy with Lymph Node Dissection: The Randomised Controlled Phase 3 PELYCAN Trial.
Neuberger M, Kowalewski KF, Simon V, von Hardenberg J, Siegel F, Wessels F, Worst TS, Michel MS, Westhoff N, Kriegmair MC, Honeck P, Nuhn P. Neuberger M, et al. Among authors: worst ts. Eur Urol Oncol. 2024 Feb;7(1):53-62. doi: 10.1016/j.euo.2023.07.009. Epub 2023 Aug 4. Eur Urol Oncol. 2024. PMID: 37543465 Clinical Trial.
A self-supervised vision transformer to predict survival from histopathology in renal cell carcinoma.
Wessels F, Schmitt M, Krieghoff-Henning E, Nientiedt M, Waldbillig F, Neuberger M, Kriegmair MC, Kowalewski KF, Worst TS, Steeg M, Popovic ZV, Gaiser T, von Kalle C, Utikal JS, Fröhling S, Michel MS, Nuhn P, Brinker TJ. Wessels F, et al. Among authors: worst ts. World J Urol. 2023 Aug;41(8):2233-2241. doi: 10.1007/s00345-023-04489-7. Epub 2023 Jun 29. World J Urol. 2023. PMID: 37382622 Free PMC article.
Changes in neutrophile-to-lymphocyte ratio as predictive and prognostic biomarker in metastatic prostate cancer treated with taxane-based chemotherapy.
Neuberger M, Weiß C, Goly N, Skladny J, Nitschke K, Wessels F, Kowalewski KF, Waldbillig F, Hartung F, Nientiedt M, Egen L, Herrmann J, Jarczyk J, Walach MT, Kriegmair MC, Westhoff N, Worst TS, Nuhn P. Neuberger M, et al. Among authors: worst ts. Discov Oncol. 2022 Dec 15;13(1):140. doi: 10.1007/s12672-022-00603-0. Discov Oncol. 2022. PMID: 36522513 Free PMC article.
Efficacy of cabazitaxel in fourth or later line of therapy in metastatic castration-resistant prostate cancer: Multi-institutional real-world experience in Germany.
Wenzel M, Borkowetz A, Lieb V, Hoffmann MA, Borgmann H, Höfner T, Dotzauer R, Neuberger M, Worst TS, von Hardenberg J, Linxweiler J, Klümper N. Wenzel M, et al. Among authors: worst ts. Urol Oncol. 2022 Dec;40(12):538.e7-538.e14. doi: 10.1016/j.urolonc.2022.09.011. Epub 2022 Oct 14. Urol Oncol. 2022. PMID: 36244915
Deep learning can predict survival directly from histology in clear cell renal cell carcinoma.
Wessels F, Schmitt M, Krieghoff-Henning E, Kather JN, Nientiedt M, Kriegmair MC, Worst TS, Neuberger M, Steeg M, Popovic ZV, Gaiser T, von Kalle C, Utikal JS, Fröhling S, Michel MS, Nuhn P, Brinker TJ. Wessels F, et al. Among authors: worst ts. PLoS One. 2022 Aug 17;17(8):e0272656. doi: 10.1371/journal.pone.0272656. eCollection 2022. PLoS One. 2022. PMID: 35976907 Free PMC article.
55 results